Audet Juliette Berangere has filed 5 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 30000 shares of NewAmsterdam Pharma Co N.V. ($NAMS) on May 01, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | NewAmsterdam Pharma Co N.V. | $NAMS | Audet Juliette Berangere | See Remarks | A | Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 94,358,067 | 9999.99% | 0.03% |
| Jan. 7, 2025 | NewAmsterdam Pharma Co N.V. | $NAMS | Audet Juliette Berangere | Chief Business Officer | A | Ordinary Shares | 14000 | $0.00 | 15,104.0000 | 94,358,067 | 1268.12% | 0.01% |
| Jan. 2, 2025 | NewAmsterdam Pharma Co N.V. | $NAMS | Audet Juliette Berangere | Chief Business Officer | A | Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 94,358,067 | 9999.99% | 0.11% |
| Sept. 26, 2024 | NewAmsterdam Pharma Co N.V. | $NAMS | Audet Juliette Berangere | Chief Business Officer | P | Ordinary Shares | 1104 | $15.70 | 1,104.0000 | 82,161,956 | 9999.99% | 0.00% |
| April 1, 2024 | NewAmsterdam Pharma Co N.V. | $NAMS | Audet Juliette Berangere | Chief Business Officer | A | Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 82,161,956 | 9999.99% | 0.30% |